Free Delivery Over $100
|
|
|||
|
||||
OverviewDue to a worldwide need for lower cost drug therapy, use of generic and multi-source drug products have been increasing. To meet international patent and trade agreements, the development and sale of these products must conform to national and international laws, and generic products must prove that they are of the same quality and are therapeutically equivalent to the brand name alternative. However, many countries have limited resources to inspect and verify the quality of all drug products for sale in their country. This title discusses the worldwide legislative and regulatory requirements for the registration of generic and multi-source drug products. Full Product DetailsAuthor: Isadore Kanfer (Rhodes University, Grahamstown, South Africa) , Leon Shargel, PhD, Rph (Applied Biopharmaceutics Applied Biopharmaceutics, Raleigh, North Carolina, USA Applied Biopharmaceutics, LLC, Raleigh, North Carolina, USA)Publisher: Informa Healthcare Imprint: Informa Healthcare ISBN: 9781282560970ISBN 10: 1282560972 Pages: 333 Publication Date: 01 January 2010 Audience: General/trade , General Format: Undefined Publisher's Status: Active Availability: In stock  We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
